Frederick, MD., Aug. 14, 2024 -- Veralox Therapeutics, a clinical-stage biotechnology company developing first-in-class therapies targeting the 12-lipoxygenase (12-LOX) pathway, announced that the European Medicines Agency (EMA) has granted Orphan...
Biotech Showcase 2023
Peter Young will be participating on a panel titled "Early Seed Financing: Funding Strategies to Prepare Start-Ups for Growth" on Wednesday, January 11th at the Biotech Showcase 2023 in San Francisco.
